Home/Filings/4/0001209191-18-031237
4//SEC Filing

Deschamps Philippe 4

Accession 0001209191-18-031237

CIK 0001610853other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 8:21 PM ET

Size

5.9 KB

Accession

0001209191-18-031237

Insider Transaction Report

Form 4
Period: 2018-05-15
Deschamps Philippe
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-05-15+95,00095,000 total
    Exercise: $10.99Exp: 2028-05-15Class A Common Stock (95,000 underlying)
Footnotes (2)
  • [F1]Translated into US dollars from Canadian dollars based on buying rate from Bank of Canada. USD $1.0000 = CAD $1.2876 on May 15, 2018; based on exercise price of CAD $14.15.
  • [F2]Grant to the Reporting Person of a stock option under the Issuer's 2016 Omnibus Incentive Plan (the "2016 Plan"). The shares vest in a series of forty-eight (48) successive equal monthly installments measured from May 15, 2018, subject to the Reporting Person's continued service through each applicable vesting date.

Issuer

HELIUS MEDICAL TECHNOLOGIES, INC

CIK 0001610853

Entity typeother

Related Parties

1
  • filerCIK 0001638231

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 8:21 PM ET
Size
5.9 KB